Valuation: Cellnovo

Market Cap 2.44M 2.18M 2.03M 1.84M 3.47M 236M 3.5M 24.4M 9.53M 120M 9.14M 8.95M 385M P/E 2018 *
-0.15x
P/E 2019 * -
Enterprise Value 12.46M 11.13M 10.38M 9.43M 17.77M 1.21B 17.9M 125M 48.75M 613M 46.77M 45.76M 1.97B EV / Sales 2018
8.63x
EV / Sales 2019 * -
Free-Float
99.67%
Yield 2018 *
-
Yield 2019 * -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 2.68M
+0.09%+3.29%+1.10%+61.88% 3,934B
+1.07%+3.78%+6.56%+1,068.69% 466B
-0.84%+4.56%-49.49%+30.56% 435B
-3.42%+2.08%+92.18%+228.81% 332B
-4.81%+0.26%+119.09%+500.92% 272B
+0.92%+1.17%-20.35%+54.55% 242B
-0.07%+2.88%-23.76%+22.94% 143B
-1.04%+5.88%+122.89%+215.84% 139B
-2.48%-0.92%+75.60%+187.35% 97.43B
Average -0.94%+2.34%+35.98%+263.50% 606.08B
Weighted average by Cap. -0.30%+3.15%+10.72%+170.32%

Financials

2018 2019 *
Net sales 3.32M 2.97M 2.77M 2.52M 4.74M 321M 4.77M 33.28M 13M 163M 12.47M 12.2M 525M -
Net income -15.94M -14.24M -13.29M -12.07M -22.73M -1.54B -22.9M -160M -62.38M -784M -59.84M -58.54M -2.52B -
Net Debt 10.02M 8.95M 8.35M 7.59M 14.29M 969M 14.4M 100M 39.22M 493M 37.63M 36.81M 1.59B -
Logo Cellnovo
Cellnovo Group SA is a France-based company principally engaged in medical instrument manufacturing . The Company specialized in the development of a mobile system for managing type 1 diabetes. Its apparatus includes a cordless micro-pump (a patch pump), an integrated monitoring device and a cellular handset with touch screen with an embedded blood glucose meter. The Company system enables diabetics to live a normal life whilst closely monitoring their glycaemia, their use of insulin, their activity and their food intake.
Employees
-
  1. Stock Market
  2. Stocks
  3. CLNV Stock